Celebrating a Career Built on Trust: Julie Dewey Inducted into IR Impact Hall of Fame

Our Chief Investor Relations and Communications Officer receives one of the profession’s highest honors

When Julie Dewey joined Orthofix in June 2024, she brought more than two decades of experience in investor relations and a reputation for doing things differently. Now, she’s been inducted into the IR Impact Hall of Fame.

It’s an honor that recognizes the best of the best in investor relations. But for those who know Julie, it’s really a recognition of something more profound: her commitment to building genuine relationships with the investment community.

What Sets Julie Apart

Julie Dewey, Chief Investor Relations and Communications Officer

Throughout her career at companies like Wright Medical Group, Nevro Corp, and Treace Medical Concepts, Julie has been recognized for elevating the entire profession. She’s won Best IR Officer honors five years running by IR Impact and was named one of IR Impact’s “30 IR Stars Over 30 Years” — but the awards tell only part of the story.

The real achievement? She has consistently been ranked the #1 IR Officer in the small to mid-cap category by Extel (formerly Institutional Investor) eight times over the past nine years. That doesn’t happen by accident. It happens because of the care she puts into every relationship and every communication.

Why This Matters for Orthofix

Julie’s Hall of Fame induction is a personal milestone and validation of the approach we take to investor relations at Orthofix. At a time when our company is growing and transforming, having someone of Julie’s caliber leading our communications with the investment community sends a powerful message.

She understands that great investor relations is about building trust through transparency, consistency, and genuine engagement. It’s about helping investors understand not just where a company is, but where it’s going and why that journey matters.

That commitment to excellence — the kind that earns Hall of Fame recognition — is exactly what we need as we execute our growth strategy and continue to deliver value to our shareholders. Julie doesn’t just understand the medical technology space; she understands how to tell our story in a way that resonates with the investment community.

Congratulations, Julie, on this well-deserved honor. Thank you for bringing your expertise and leadership to Orthofix every day.


Learn more about Julie’s Hall of Fame induction: IR Impact Hall of Fame Profile

Learn more about how Orthofix builds lasting investor relationships through transparency and growth — visit our Investor Relations and Why Invest in Orthofix page.